{"id":"W2167567290","doi":"10.1016/s1474-4422(14)70198-x","title":"Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Donepezil; Placebo; Medicine; Clinical endpoint; Montreal Cognitive Assessment; Internal medicine; Alzheimer's disease; Clinical trial; Randomized controlled trial; Disease; Dementia; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001678366,0.001854479,0.003704645,0.0004729574,0.0004545533,0.001088037,0.0009063719,0.002155894,0.005456068],"category_scores_gemma":[0.001893175,0.0008866489,0.002108856,0.0003737957,0.001073172,0.001194248,0.0004591479,0.002820461,0.001002266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007855817,"about_ca_system_score_gemma":0.0008905126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00126463,"about_ca_topic_score_gemma":0.00264074,"domain_scores_codex":[0.9994665,0.0002317903,0.00004594737,0.0001093918,0.00004636545,0.0001000311],"domain_scores_gemma":[0.999243,0.0002052733,0.0001686302,0.00006283637,0.00005187905,0.0002682544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9871393,0.002204502,0.0004298268,0.000548573,0.0007176708,0.00003295622,0.00004337648,0.0001049419,0.001952263,0.00005138823,0.0004371212,0.006338103],"study_design_scores_gemma":[0.9692314,0.02813133,0.001590602,0.00002176933,0.000382626,0.00002044084,0.00001210745,0.0001117402,0.0001458014,0.00006233858,0.0002782781,0.00001145444],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811904,0.009936348,0.0006771568,0.0007748124,0.0005829429,0.002432123,0.001662473,0.0001667247,0.002577005],"genre_scores_gemma":[0.9834135,0.005494518,0.001346831,0.001485585,0.0005017807,0.002743511,0.001903997,0.00002668227,0.003083498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005456068,"threshold_uncertainty_score":0.01825231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02550439855798756,"score_gpt":0.3142197630202742,"score_spread":0.2887153644622866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}